Nebula Research & Development’s Cardinal Health CAH Stock Holding History

Nebula Research & Development’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-10,334	Closed	-$1.74M	–	142
2025 Q2	$1.74M	Buy	10,334 +2,646	+34%	+$393K	0.15%	227
2025 Q1	$1.06M	Buy	+7,688	New	+$980K	0.1%	354
2024 Q4	–	Sell	-13,723	Closed	-$1.52M	–	917
2024 Q3	$1.52M	Buy	13,723 +10,301	+301%	+$1.08M	0.18%	156
2024 Q2	$336K	Buy	+3,422	New	+$349K	0.05%	569
2024 Q1	–	Sell	-2,407	Closed	-$243K	–	757
2023 Q4	$243K	Sell	2,407 -2,419	-50%	-$240K	0.07%	496
2023 Q3	$419K	Buy	+4,826	New	+$436K	0.22%	178

Other funds holding CAH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nebula Research & Development's CAH Position: Q3 2025 in Review

Nebula Research & Development sold out of Cardinal Health (CAH) in Q3 2025, closing a stake of 10,334 shares — an estimated $1.74M sold.

Nebula Research & Development first reported a position in CAH in Q3 2023 and held it in 6 quarters. The position peaked at $1.74M in Q2 2025. 1,222 funds tracked by Wall St. Rank hold CAH as of Q3 2025.

Nebula Research & Development reported no remaining Cardinal Health position as of Q3 2025 after selling out during the quarter.
Nebula Research & Development sold 10,334 Cardinal Health shares in Q3 2025, an estimated $1.74M.
Nebula Research & Development first reported a position in Cardinal Health in Q3 2023 and held it in 6 quarters.
Nebula Research & Development's Cardinal Health position peaked at $1.74M in Q2 2025.
1,222 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2025.

Based on Nebula Research & Development's 13F filing for Q3 2025.